+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Not all patients might benefit from gastric by-pass

Not all patients might benefit from gastric by-pass

Revue Medicale Suisse 12(511): 597-8, 600-1

Obesity is a chronic disease with a need for long-term follow-up. Bariatric surgery is very beneficial for patients who are not able to lose weight by lifestyle modifications alone. However, some patients present a weight regain after surgery. Predictive factors for the evolution of weight loss after bariatric surgery are not available today. For that reason, all preventive and therapeutic facilities should be used in order to reduce the risk of relapse after surgery. A recently introduced multidisciplinary therapeutic program for preparation of patients before bariatric surgery could be very valuable for a sustainable change of their lifestyle in order to minimize the risk of weight regain in the years after surgery.

(PDF emailed within 1 workday: $29.90)

Accession: 058427636

Download citation: RISBibTeXText

PMID: 27188053

Related references

Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?. British Journal of Radiology 89(1059): 20150758-20150758, 2016

Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer. International Journal of Clinical Oncology (): -, 2016

The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma. European Journal of Cancer Care 17(1): 26-32, 2008

Value of E-PASS and mE-PASS in predicting morbidity and mortality of gastric cancer surgery. Zhonghua Zhong Liu Za Zhi 37(10): 753-758, 2016

Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2. Polski Przeglad Chirurgiczny 83(2): 81-86, 2012

A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer. Japanese Journal of Clinical Oncology 33(5): 238-240, 2003

Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Annals of Surgical Oncology 7(3): 210-217, 2000

Gastric cancer: which patients benefit from systematic lymphadenectomy?. European Journal of Surgical Oncology 26(5): 498-505, 2000

Do patients with pN gastric cancer benefit from prophylactic extended lymphadenectomy?. 2011

Laparoscopic gastric banding in therapy of obesity. Which patients benefit?. Mmw Fortschritte der Medizin 143(33-34): 22-24, 2001

Is the follow-up of patients operated on for gastric carcinoma of benefit to the patient?. Hepato-Gastroenterology 39(1): 14-16, 1992

Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?. Surgical Oncology 21(1): E7-11, 2012

Too many proposals pass the benefit cost test. American economic review 79(3): 544-551, 1989

Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?. Medical Oncology 32(2): 476-476, 2015

E-PASS comprehensive risk score is a good predictor of postsurgical mortality from comorbid disease in elderly gastric cancer patients. Journal of Surgical Oncology 109(6): 586-592, 2014